AU7604596A - A method of treating myotonic dystrophy - Google Patents

A method of treating myotonic dystrophy

Info

Publication number
AU7604596A
AU7604596A AU76045/96A AU7604596A AU7604596A AU 7604596 A AU7604596 A AU 7604596A AU 76045/96 A AU76045/96 A AU 76045/96A AU 7604596 A AU7604596 A AU 7604596A AU 7604596 A AU7604596 A AU 7604596A
Authority
AU
Australia
Prior art keywords
myotonic dystrophy
treating myotonic
treating
dystrophy
myotonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76045/96A
Inventor
Dean Lockwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU7604596A publication Critical patent/AU7604596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76045/96A 1995-11-17 1996-11-04 A method of treating myotonic dystrophy Abandoned AU7604596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US737395P 1995-11-17 1995-11-17
US007373 1995-11-20
PCT/US1996/017633 WO1997018811A1 (en) 1995-11-17 1996-11-04 A method of treating myotonic dystrophy

Publications (1)

Publication Number Publication Date
AU7604596A true AU7604596A (en) 1997-06-11

Family

ID=21725788

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76045/96A Abandoned AU7604596A (en) 1995-11-17 1996-11-04 A method of treating myotonic dystrophy

Country Status (3)

Country Link
AU (1) AU7604596A (en)
WO (1) WO1997018811A1 (en)
ZA (1) ZA969591B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
CA2639412A1 (en) 2007-09-11 2009-03-11 Universite Laval Prostaglandin e2 modulation and uses thereof
EP2552435A1 (en) * 2010-04-02 2013-02-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (en) * 1983-08-30 1985-03-22 Sankyo Co Ltd Thiazolidine derivative and its preparation
US5120754A (en) * 1988-03-08 1992-06-09 Pfizer Inc. Thiazolidinedione hypoglycemic agents
US4897405A (en) * 1989-04-21 1990-01-30 American Home Products Corporation Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
GB8919434D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
WO1997018811A1 (en) 1997-05-29
ZA969591B (en) 1997-06-02

Similar Documents

Publication Publication Date Title
AU6430794A (en) A method of treating endo-osteal materials
AU3363095A (en) A method of treatment for malaria
AU1683395A (en) A method of treating glaucoma
AU2679195A (en) A method of coating
AU2074097A (en) Method for bulk coating using a plasma process
AU3101795A (en) Method of making a benzylpropanamine
AU4494996A (en) A method of printing
AU6051996A (en) A method of coating glass
AU7138896A (en) A method of oxidation
AU5795096A (en) Carton engaging assembly and method
AU1718097A (en) Method of manufacturing containers
AU1020997A (en) Method of treating sepsis
AU4644996A (en) Method of recycling fluids
AU1178395A (en) Method of treating muscular dystrophy
AU7440596A (en) Sewage process method
AU5311896A (en) Method of oxychlorination
AU2799195A (en) A method of creating an effect
AU7604596A (en) A method of treating myotonic dystrophy
AU7037994A (en) A method of galvanising
AU3058095A (en) A method of forming sulphur
AU1632095A (en) Coating process
AU5423496A (en) A method of forming a structural panel
AU4453696A (en) Method for reducing stain
AU7280696A (en) A method of treating filariae
AU7117696A (en) Gas treating process